Product Program year 2025 Source: CMS Open Payments

Arthrex

Device Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Revers - Cups

PDI 00888867406889

Open in the dashboard

General payments

$14,349,971

32 payments

Research payments

$0

0 payments

Through program year 2025, $14,349,971 in general payments and $0 in research payments were reported against Arthrex (Revers - Cups).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $14,349,971 32

Breakdown

Who paid General payments · program year 2025
  1. Arthrex, Inc. $14,349,971 32 payments
Top recipients General payments · program year 2025
  1. Anthony Romeo Orthopaedic Surgery · New York, NY $6,567,919 46% · 5 payments
  2. Reuben Gobezie Orthopaedic Surgery · Cleveland, OH $2,656,370 19% · 4 payments
  3. Evan Lederman Orthopaedic Surgery · Phoenix, AZ $2,650,493 18% · 4 payments
  4. Christopher Ahmad Orthopaedic Surgery · New York, NY $1,427,073 10% · 17 payments
  5. Brian Cohen Orthopaedic Surgery · Chillicothe, OH $1,048,117 7% · 2 payments

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $14,349,971 100% · 5 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. New York $7,994,992 56% · 2 recipients
  2. Ohio $3,704,487 26% · 2 recipients
  3. Arizona $2,650,493 18% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

32 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record